Clinical, epidemiological and virological features of acute hepatitis B in Italy

Infection

Volumn 43, Issue 4, 2015, Pages 431-441

  Zuccaro, Ornella ^a   Romanò, Luisa ^b   Mele, Alfonso ^a   Mariano, Andrea ^c   Clementi, Massimo ^d   Tosti, Maria Elena ^a   Taliani, Gloria ^e   Galli, Claudio ^f   Zanetti, Alessandro Remo ^b   Spada, Enea ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^d SAN RAFFAELE HOSPITAL   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f ABBOTT DIAGNOSTICS   (Italy)

Author keywords

Acute infection; Epidemiology; Genotypes; Hepatitis B; Mutations; Risk factors

Indexed keywords

BILIRUBIN; HEPATITIS B(E) ANTIGEN; HEPATITIS B CORE ANTIGEN; HEPATITIS B VACCINE;

ACUTE HEPATITIS B; ADOLESCENT; ADULT; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; EPIDEMIOLOGY; FEMALE; FOLLOW UP; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE; HEALTH HAZARD; HEPATITIS B VIRUS; HEPATITIS B VIRUS GENOTYPE A; HEPATITIS B VIRUS GENOTYPE D; HEPATITIS B VIRUS GENOTYPE F; HIGH RISK BEHAVIOR; HUMAN; IMMIGRATION; ITALY; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; SEQUENCE ANALYSIS; SEXUAL BEHAVIOR; VACCINATION; VERY ELDERLY; VIREMIA; VIRUS DETECTION; VIRUS GENE; ACUTE DISEASE; COHORT ANALYSIS; GENETICS; HEPATITIS B; ISOLATION AND PURIFICATION; MIDDLE AGED; VIROLOGY; YOUNG ADULT;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HEPATITIS B; HEPATITIS B CORE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; ITALY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84938416743     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-015-0747-0     Document Type: Article

References (38)

1. Liaw YF, Chu CM. Hepatitis B virus infection. Lancet. 2009;373:582–92.
2. World Health Organization (WHO). Available, from: http://www.who.int/mediacentre/factsheets/fs204/en/. Updated April 2014.
3. Romanò L, Velati C, Cambiè G, et al. Hepatitis B virus infection among first-time blood donors in Italy: prevalence and correlates between serological patterns and occult infection. Blood Transfus. 2013;1:281–8.
4. Stroffolini T, Guadagnino V, Rapicetta M, et al. The impact of a vaccination campaign against hepatitis B on the further decrease of hepatitis B virus infection in a southern Italian town over 14 years. Eur J Intern Med. 2012;23:e190–2.
5. Fabris P, Baldo V, Baldovin T, et al. Changing epidemiology of HCV and HBV infections in Northern Italy: a survey in the general population. J Clin Gastroenterol. 2008;42:527–32.
6. Integrated epidemiological system for acute viral hepatitis. Available, from: http://www.iss.it/seieva/. Updated April 2014.
7. Mele A, Tosti ME, Mariano A, et al. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges. Clin Infect Dis. 2008;46:868–75.
8. Palumbo E, Scotto G, Cibelli DC, et al. Immigration and hepatitis B virus: epidemiological, clinical and therapeutic aspects. East Mediterr Health J. 2008;14:784–90.
9. Fasano M, Saracino A, Carosi G, et al. Hepatitis B and immigrants: a SIMIT multicenter cross-sectional study. Infection. 2013;41:53–9.
10. Shi YH. Correlation between hepatitis B virus genotypes and clinical outcomes. Jpn J Infect Dis. 2012;65:476–82.
11. Lin CL, Kao JH. The clinical implications of hepatitis B virus genotype: recent advances. J Gastroenterol Hepatol. 2011;26:123–30.
12. Ozasa A, Tanaka Y, Orito E, et al. Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection. Hepatology. 2006;44:326–34.
13. Ehata T, Omata M, Chuang WL, et al. Mutations in core nucleotide sequence of hepatitis B virus correlate with fulminant and severe hepatitis. J Clin Invest. 1993;91:1206–13.
14. Dal Molin G, Poli A, Crocè LS, D’Agaro P, et al. Hepatitis B virus genotypes, core promoter variants, and precore stop codon variants in patients infected chronically in North-Eastern Italy. J Med Virol. 2006;78:734–40.
15. Brunetto MR, Giarin MM, Oliveri F, et al. Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis. Proc Natl Acad Sci USA. 1991;88:4186–90.
16. De Mitri MS, Cassini R, Morsica G, et al. Virological analysis, genotypes and mutational patterns of the HBV precore/core gene in HBV/HCV-related hepatocellular carcinoma. J Viral Hepat. 2006;13:574–81.
17. Coppola N, Masiello A, Tonziello G, et al. Factors affecting the changes in molecular epidemiology of acute hepatitis B in a Southern Italian area. J Viral Hepat. 2010;17:493–500.
18. Scalia G, Russo R, Palermo I, et al. Clinical, virological and epidemiological aspects of acute B hepatitis in the Catania area (Italy). Infez Med. 2010;18:169–74.
19. Coppola N, Sagnelli C, Pisaturo M, et al. Clinical and virological characteristics associated with severe acute hepatitis B. Clin Microbiol Infect. 2014;20:O991–7. doi:10.1111/1469-0691.12720.
20. Stroffolini T, Rapicetta M, Lombardo F, et al. Historical study of acute hepatitis B in subjects with or without hepatitis C infection. Eur J Intern Med. 2012;23:e146–9.
21. Rodella A, Galli C, Terlenghi L, et al. Quantitative analysis of HBsAg, IgM anti-HBc and anti-HBc avidity in acute and chronic hepatitis B. J Clin Virol. 2006;37:206–12.
22. Chan HL, Hussain M, Lok AS. Different hepatitis B virus genotypes are associated with different mutations in the core promoter and precore regions during hepatitis B e antigen seroconversion. Hepatology. 1999;29:976–84.
23. Chemin I, Zoulim F, Merle P, et al. High incidence of hepatitis B infections among chronic hepatitis cases of unknown aetiology. J Hepatol. 2001;34:447–54.
24. Sagnelli C, Ciccozzi M, Pisaturo M, et al. Molecular epidemiology of hepatitis B virus genotypes circulating in acute hepatitis B patients in the Campania region. J Med Virol. 2014;86:1683–93.
25. Kobayashi M, Ikeda K, Arase Y, et al. Change of hepatitis B virus genotypes in acute and chronic infections in Japan. J Med Virol. 2008;80:1880–4.
26. Tamada Y, Yatsuhashi H, Masaki N, et al. Hepatitis B virus strains of subgenotype A2 with an identical sequence spreading rapidly from the capital region to all over Japan in patients with acute hepatitis B. Gut. 2012;61:765–73.
27. Yotsuyanagi H, Okuse C, Yasuda K, et al. Distinct geographic distributions of hepatitis B virus genotypes in patients with acute infection in Japan. J Med Virol. 2005;77:39–46.
28. van Houdt R, Bruisten SM, Koedijk FD, et al. Molecular epidemiology of acute hepatitis B in the Netherlands in 2004: nationwide survey. J Med Virol. 2007;79:895–901.
29. Sloan RD, Strang AL, Ramsay ME, et al. Genotyping of acute HBV isolates from England, 1997-2001. J Clin Virol. 2009;44:157–60.
30. Yotsuyanagi H, Ito K, Yamada N, et al. High levels of hepatitis B virus after the onset of disease lead to chronic infection in patients with acute hepatitis B. Clin Infect Dis. 2013;57:935–42.
31. Ito K, Yotsuyanagi H, Yatsuhashi H, et al. Risk factors for long-term persistence of serum hepatitis B surface antigen following acute hepatitis B virus infection in Japanese adults. Hepatology. 2014;59:89–97.
32. Lok AS, Akarca U, Greene S. Mutations in the pre-core region of hepatitis B virus serve to enhance the stability of the secondary structure of the pre-genome encapsidation signal. Proc Natl Acad Sci USA. 1994;91:4077–81.
33. Chulanov VP, Shipulin GA, Schaefer S, et al. Kinetics of HBV DNA and HBsAg in acute hepatitis B patients with and without coinfection by other hepatitis viruses. J Med Virol. 2003;69:313–23.
34. Hyams KC. Risks of chronicity following acute hepatitis B virus infection: a review. Clin Infect Dis. 1995;20:992–1000.
35. Schillie SF, Spradling PR, Murphy TV. Immune response of hepatitis B vaccine among persons with diabetes: a systematic review of the literature. Diabetes Care. 2012;35:2690–7.
36. Tacke F, Amini-Bavil-Olyaee S, Heim A, et al. Acute hepatitis B virus infection by genotype F despite successful vaccination in an immune-competent German patient. J Clin Virol. 2007;38:353–7.
37. Ren F, Tsubota A, Hirokawa T, et al. A unique amino acid substitution, T126I, in human genotype C of hepatitis B virus S gene and its possible influence on antigenic structural change. Gene. 2006;383:43–51.
38. Sticchi L, Caligiuri P, Cacciani R, et al. Epidemiology of HBV S-gene mutants in the Liguria Region, Italy: implications for surveillance and detection of new escape variants. Hum Vaccin Immunother. 2013;9:568–71.